|
Match
|
Document |
Document Title |
|
|
7071233 |
Antimicrobial prevention and treatment of human immunedeficience virus and other infectious diseases
An improved medical treatment and medicine is provided to quickly and safely resolve HIV and other microbial infections. The inexpensive medicine can be self administered and maintained for the...
|
|
|
7056900 |
Disaccharide derivatives for treating hyperglycaemia
The invention relates to the use of the disaccharide derivatives 3′-aminosucrose, sucrose-C6-acid and palatinose-C6′-acid and/or of an amide or alkyl ester thereof for the prevention or...
|
|
|
7056898 |
Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
Provided are compounds and compositions thereof that are useful for treating inflammation, particularly pulmonary inflammations including asthma and asthma-related pathologies such as allergy. Also...
|
|
|
7056889 |
Compounds that bind P2Y2 or P2Y1 receptors
The invention provides peptides and compounds that can bind to P2Y 2 receptors that are useful for modulating the secretion of mucus within mucosal surfaces.
|
|
|
7056899 |
Disaccharide derivatives for treating hyperglycaemia
The invention relates to the use of the disaccharide derivatives 3′-aminosucrose, sucrose-C6-acid and palatinose-C6′-acid and/or of an amide or alkyl ester thereof for the prevention or...
|
|
|
7048918 |
Insect bait
Disclosed are insect baits for attracting insects such as ants, flies and cockroaches. The baits include amino acids and a sugar. The baits can be combined with an insect toxicant to effectively...
|
|
|
7041651 |
Cellular uptake of bioactive agents
Provided is a composition and a method for increasing cellular uptake of bioactive agents, particularly those compounds termed “small molecules” into the cells of mammalian tissue, such as the...
|
|
|
7034006 |
Use of lipid conjugates in the treatment of disease
The invention provides novel methods for treating disease based upon the medicinal use of lipids and phospholipids covalently bound to physiologically acceptable monomers or polymers....
|
|
|
7022682 |
Method for the treatment of diabetes
The present invention provides for a method for treatment and prevention of Type II Diabetes Mellitus and its complications comprising the step of administering to a patient a...
|
|
|
7015200 |
Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
The present invention provides compositions comprising at least one GHB moiety bonded to at least one physiologically compatible carrier molecule. The compositions can enhance the uptake of the...
|
|
|
7001892 |
Pharmaceutical materials and methods for their preparation and use
Pharmaceutical compositions comprising crystals of a pharmaceutically-acceptable crystal lattice component, and an active pharmaceutical ingredient different from and included within the crystal...
|
|
|
6979679 |
Composition and method for treatment and prevention of traumatic synovitis and damage to articular cartilage
The invention provides compositions useful for the treatment and/or prevention of damage to diarthrodial (synovial) joints and, in particular, traumatic synovitis, inflammation of the synovial...
|
|
|
6974804 |
Esters
Acylated cellobiose compounds (CHME) which satisfy the formula;
wherein
X represents an acyl group (R—CO—) or H, Z represents an acyl group (R′—CO—) or H and not more than a...
|
|
|
6964949 |
Pharmaceutical compositions for promoting the growth of gram-positive bacilli and increasing the acidity in the vagina and the use thereof
The present invention relates to a pharmaceutical formulation for stimulating the growth of gram-positive bacilli and increasing the acidity in the vagina which comprises sucrose and/to maltose, to...
|
|
|
6953574 |
Method for producing a fermented hydrolyzed medium containing microorganisms
A method of producing a hydrolyzed fermented medium containing microorganisms includes providing at least one solid plant product reduced to small pieces and mixed with sugar and biocompatible...
|
|
|
6953592 |
Water soluble powders and tablets
The invention relates to water soluble or water dispersible powders, tablets, or precursors therefor based on a carbohydrate matrix with improved dissolution properties in water. These components...
|
|
|
6949523 |
Aglycon dammarane sapogenins, their use as anti-cancer agents, and a process for producing same
This invention relates to a group of novel sapogenins, their use in anti-cancer applications, and to a process for their production. More particularly, this invention pertains to a novel group of...
|
|
|
6946490 |
Antimicrobial treatment for herpes simplex virus and other infectious diseases
An improved medical treatment and medicine is provided to quickly and safely resolve herpes and other microbial infections. The inexpensive user-friendly medicine can be applied and maintained on...
|
|
|
6946451 |
Insulin secretion promoter
Provided are a method for promoting insulin secretion, a method for suppressing the elevation of a blood glucose level, a method for ameliorating diabetes mellitus, a method for promoting growth of...
|
|
|
6942858 |
Compositions containing bacteriophages and methods of using bacteriophages to treat infections
Purified, host-specific, non-toxic, wide host range and virulent bacteriophage preparations that are effective in killing bacterial organisms in vivo are disclosed. Also disclosed are compositions...
|
|
|
6943154 |
Water insoluble derivatives of polyanionic polysaccharides
A water insoluble, biocompatible composition that is formed by a method which combines, in an aqueous mixture, a polyanionic polysaccharide, a nucleophile, and an activating agent, under conditions...
|
|
|
6939668 |
Compositions and methods for treatment of lung transplants
Methods and compositions for pre-treatment of lung transplants to reduce susceptibility to post-operative B. cepacia infection are provided. The methods and compositions employ saccharides,...
|
|
|
6939858 |
Malto-oligosaccharide derivatives and use thereof
The present invention provides a substance which strongly inhibits human α-amylase and is effective for the prevention and treatment of hyperglycemia, for example, diabetes and the diseases caused...
|
|
|
6936588 |
Method of production of an isomaltulose-containing enteral nutrient
The present invention relates to a method for the production and use of enteral nutrients, particularly an enteral solution, wherein this method is distinguished by a particularly gentle...
|
|
|
6919172 |
Preservation and storage medium for biological materials
A protectant mixture for use in preserving biological materials comprising (1) at least one polyhydroxy compound, where the total amount of polyhydroxy compound in the mixture is from about 5% to...
|
|
|
6911436 |
Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
The invention discloses the discovery that a pharmaceutical composition containing complex carbohydrates and natural or synthetic essential oils can work effectively as a topical pharmaceutical...
|
|
|
6908904 |
Pharmaceutical preparation and method for treatment of diabetes
A method for treatment of a diabetic condition, wherein a therapeutically effective amount of at least one isoform of sulfatide is administered to a patient, wherein said at least one isoform of...
|
|
|
6899900 |
Composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator
Disclosed are a multipurpose, high-functional, alkaline solution composition, preparation therefor and use thereof as a nonspecific immunostimulator. The composition comprises 1-25 parts by weight...
|
|
|
6897198 |
Method of treatment with combinations of statin and aryl-substituted propanolamine derivatives
Substituted propanolamine derivatives, their pharmaceutically tolerated salts and physiologically functional derivatives thereof are described. Also described are compounds of formula I
in...
|
|
|
6897202 |
Powder comprising water-containing β-maltose crystals and production process and use thereof
The object of the present invention is to provide a powdery product comprising crystalline β-maltose monohydrate which is powderized by spray method, and has a high-solubility in aqueous solvents...
|
|
|
6894071 |
Medical compositions for intravesical treatment of bladder cancer
Anti-cancer coating compositions comprising 3-hydroxymethyl-5-aziridinyl-1-1-methyl-2-[1H-indole-4,7-dio
ne]propenol (E09) are disclosed. More specifically, the coating compositions comprise EO9...
|
|
|
6890906 |
Method for controlling angiogenesis in animals
Disease conditions which are dependent upon or moderated by angiogenesis are controlled by the use of a therapeutic material which interacts with cell surface galectins. Particular therapeutic...
|
|
|
6852707 |
Remedies for hyperammonemia
By using xylobiose or xylooligosaccharide containing xylobiose as a main ingredient in place of lactulose, there is provided a blood ammonia lowering agent, a therapeutic agent of hyperammonemia or...
|
|
|
6838480 |
Composition containing sucrafate and a topical anesthetic for humans and animals and method of use thereof
A composition and method of treating plurality of conditions utilizes a combination of sucralfate and a topical anesthetic such as lidocaine. The composition finds utility in treating the symptoms...
|
|
|
6833362 |
Method and composition for the accelerated in vivo removal of ethanol
A composition for accelerating the disposal of ethanol from bodily fluid. Certain additives can accelerate the metabolic oxidation of ethanol, and others in addition act as catalysts or...
|
|
|
6825173 |
Preparation of fagopyritols and uses therefor
The present invention describes isolated Fagopyritol A1, isolated Fagopyritol A3, and isolated Fagopyritol B3. Compositions which include two or more of Fagopyritol A1, Fagopyritol A2, Fagopyritol...
|
|
|
6815435 |
Pharmaceutical compositions containing DDS compounds
A pharmaceutical composition having an ensured preservation stability, which contains a compound, wherein a polysaccharide derivative having a carboxyl group is bonded to a camptothecin derivative...
|
|
|
6812222 |
Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
The present invention relates to a peritoneal dialysis solution comprising at least one amino sugar in an effective amount sufficient to create an osmotic pressure to effect the removal of water by...
|
|
|
6797705 |
Rhamnan sulphate composition for treatment of endothelial dysfunction
The invention described is a method and composition for inducing cell surface anti-thrombotic activity in endothelial cells comprising administering to a patient a therapeutically-effective amount...
|
|
|
6780411 |
Tissue sealant compositions
Tissue sealant compositions containing human recombinant fibrinogen, human recombinant factor XIII and human recombinant thrombin. Also disclosed are preferred formulations and uses therefore.
|
|
|
6777391 |
Composition for an infant formula having a low threonine content
A composition for an infant formula which comprises a low threonine content; a method of producing the composition; use of the composition in the manufacture of a medicament or nutritional product...
|
|
|
6777397 |
Mixtures of fructose and lactose as a low-calorie bulk sweetener with reduced glycemic index
Mixtures of fructose and lactose are useful for reducing caloric intake and glycemic index for individuals who are overweight, glucose-impaired, diabetic, or who just consume too large a fraction...
|
|
|
6750209 |
Advanced glycation end-product intermediaries and post-amadori inhibition
The instant invention provides compositions and methods for modeling post-Amadori AGE formation and the identification and characterization of effective inhibitors of post-Amadori AGE formation,...
|
|
|
6737405 |
Stabilized protein preparation and process for its preparation
A stabilized protein preparation is described which contains no antithrombin III and is protected against loss of activity during pasteurization by the addition of stabilizers which comprise one or...
|
|
|
6723704 |
Sphingoglycolipid
A glycosphingolipid having a sugar chain containing α-glucosamine and β-glucosamine is disclosed. Such glycosphingolipid is advantageous in that possibly being manufactured in a facile and...
|
|
|
6722062 |
Capsular polysaccharides from enterococci
The present invention is directed to a method for purifying polysaccharides capable of inducing the production of high titers of opsonic antibodies that kill strains of enterococcal bacteria. In...
|
|
|
6703371 |
Preparations for reducing oxygen consumption during physical efforts
The invention relates to pharmaceutically active substances from the group comprising midazolam and compounds with a methyl-substituted nitrogen atom that is the ring atom of a nitrogenous...
|
|
|
6703050 |
Methods and compositions for the prevention or treatment of cancer
Provided are agents that can bind to copper, and form a tripartite complex with protein, and the use of these agents in the prevention and treatment of diseases with a vascular component, such as...
|
|
|
6699847 |
Antiparasitic formulation
Long-acting antiparasitic formulations of doramectin, suitable for injection, are described herein.
|
|
|
6699846 |
Mono- and disaccharides for the treatment of nitric oxide related disorders
Methods for treating diseases or conditions modulated or ameliorated by nitric oxide, particularly ischemia and reperfusion injury, are provided, using glycolipids structurally related to...
|